EXPRESSION OF HUMAN CHORIONIC-GONADOTROPIN (HCG) LUTEINIZING-HORMONE RECEPTORS AND REGULATION OF THE CYCLOOXYGENASE-1 GENE BY EXOGENOUS HCGIN HUMAN FETAL MEMBRANES
P. Toth et al., EXPRESSION OF HUMAN CHORIONIC-GONADOTROPIN (HCG) LUTEINIZING-HORMONE RECEPTORS AND REGULATION OF THE CYCLOOXYGENASE-1 GENE BY EXOGENOUS HCGIN HUMAN FETAL MEMBRANES, The Journal of clinical endocrinology and metabolism, 81(3), 1996, pp. 1283-1288
The present study characterized hCG/LH receptors from messenger ribonu
cleic acid (mRNA) to protein and whether exogenous hCG can bind and re
gulate the expression of the cyclooxygenase-1 (COX-1) gene in human fe
tal membranes from term pregnancy. Northern blotting showed that fetal
membranes contain 6.0, 4.4, 2.4, and 1.4 kilobases of hCG/LH receptor
mRNA transcripts. In situ hybridization revealed that amnion, chorion
, and decidua contain receptor transcripts. Western immunoblotting and
immunocytochemistry showed that amnion, chorion, and decidua also con
tain an 80-kDa receptor protein. Ligand blotting demonstrated that the
80-kDa receptor protein in fetal membranes can bind [I-125]hCG, and t
his binding was inhibited by excess unlabeled hCG. Treatment of fetal
membranes with highly purified hCG resulted in a dose- and time-depend
ent increase in immunoreactive COX-1 protein. The response of hCG was
seen in all layers of fetal membranes. The treatment with hCG also res
ulted in an increase in steady state COX-1 mRNA levels. The action of
hCG was prevented by cotreatment with H-89, an inhibitor of protein ki
nase A, but not by calphostin or lavendustin, which inhibit protein ki
nase C and tyrosine kinase, respectively. In summary, human fetal memb
ranes contain hCG receptor transcripts and receptor protein that can b
ind hCG and up-regulate the expression of COX-1 gene.